• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Single-cell transcriptome atlas of peripheral immune features to Omicron breakthrough infection under booster vaccination strategie

tetano

Editor, Senior Moderator
Front Immunol


. 2025 Jan 6:15:1460442.
doi: 10.3389/fimmu.2024.1460442. eCollection 2024. Single-cell transcriptome atlas of peripheral immune features to Omicron breakthrough infection under booster vaccination strategies

Yuwei Zhang[SUP] 1 [/SUP], Shanshan Han[SUP] 2 [/SUP], Qingshuai Sun[SUP] 2 [/SUP], Tao Liu[SUP] 3 [/SUP], Zixuan Wen[SUP] 4 [/SUP], Mingxiao Yao[SUP] 1 [/SUP], Shu Zhang[SUP] 1 [/SUP], Qing Duan[SUP] 1 [/SUP], Xiaomei Zhang[SUP] 1 [/SUP], Bo Pang[SUP] 1 [/SUP], Zengqiang Kou[SUP] 1 [/SUP], Xiaolin Jiang[SUP] 2 4 5 [/SUP]



Affiliations
Abstract

Introduction: The high percentage of Omicron breakthrough infection in vaccinees is an emerging problem, of which we have a limited understanding of the phenomenon.
Methods: We performed single-cell transcriptome coupled with T-cell/B-cell receptor (TCR/BCR) sequencing in 15 peripheral blood mononuclear cell (PBMC) samples from Omicron infection and naïve with booster vaccination.
Results: We found that after breakthrough infection, multiple cell clusters showed activation of the type I IFN pathway and widespread expression of Interferon-stimulated genes (ISGs); T and B lymphocytes exhibited antiviral and proinflammatory-related differentiation features with pseudo-time trajectories; and large TCR clonal expansions were concentrated in effector CD8 T cells, and clonal expansions of BCRs showed a preference for IGHV3. In addition, myeloid cells in the BA.5.2 breakthrough infection with the fourth dose of aerosolized Ad5-nCoV were characterized by enhanced proliferation, chemotactic migration, and antigen presentation.
Discussion: Collectively, our study informs the comprehensive understandings of immune characterization for Omicron breakthrough infection, revealing the positive antiviral potential induced by booster doses of vaccine and the possible "trained immunity" phenomenon in the fourth dose of aerosolized Ad5-nCoV, providing a basis for the selection of vaccination strategies.

Keywords: COVID-19; Omicron; booster vaccination; breakthrough infection; peripheral immune responses; scRNA-seq.

 
Back
Top Bottom